Coty Inc header image

Coty Inc

COTY

Equity

ISIN US2220702037 / Valor 1645885

New York Stock Exchange, Inc (2024-09-18)
USD 9.26%

Coty Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Coty Inc. is a global beauty company with a history that spans over a century, marking its significance in transforming the beauty industry into what it is today. The company boasts a diverse portfolio of over 50 iconic cosmetic, skincare, and fragrance brands. Coty's business strategy is rooted in innovation and excellence, aiming to empower and enable all visions of beauty through its products. The company emphasizes the importance of science and passion as key drivers behind its mission to offer new, innovative, and science-based beauty solutions. Coty Inc. positions itself as a forward-thinking entity in the beauty sector, dedicated to supporting diverse and evolving concepts of beauty that resonate with individuals on a personal level.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Net Revenue Growth

In 3Q24, Coty Inc's Consumer Beauty net revenues increased by 6% on both a reported and like-for-like (LFL) basis. On a year-to-date basis, Consumer Beauty revenues saw an 8% increase on a reported basis and a 7% increase on an LFL basis. This growth was driven by strong performance in color cosmetics, mass fragrances, and mass skin & body care across most countries, which offset market weakness in U.S. mass cosmetics.

Regional Performance

In 3Q24, Coty Inc's Americas net revenues rose by 8% on a reported basis and 11% on an LFL basis. This growth was driven by strong double-digit percentage increases in Latin America, Canada, and the Travel Retail channel, despite a 2% negative impact from foreign exchange (FX) and a 1% headwind from the divestiture of the Lacoste license. EMEA's net revenues increased by 7% on a reported basis and 9% on an LFL basis, supported by growth across most markets and the Travel Retail channel.

Gross Margin and Operating Income

Coty Inc delivered strong gross margin expansion in 3Q24, with reported and adjusted gross margin reaching 64.8%, an increase of 190 basis points year-over-year. The improvement was driven by premiumization, carryover pricing, easing inflation, and supply chain productivity savings. The company generated a reported operating income of $77.8 million, up 79% year-over-year, resulting in a 220 basis point expansion in reported operating margin to 5.6%.

Net Income and EBITDA

In 3Q24, Coty Inc reported a net income of $0.5 million, a decrease from $105.1 million in the prior year. Adjusted net income was $43.8 million, down from $168.1 million. The decline was primarily due to mark-to-market losses from forward repurchase contracts in the current period compared to gains in the prior period. Adjusted EBITDA grew by 10% year-over-year to $199.9 million, driving a 30 basis point increase in adjusted EBITDA margin to 14.4%.

Cash Flow and Debt

In 3Q24, Coty Inc's cash flow from operating activities was $(170.0) million, and free cash flow was $(234.3) million, consistent with the company's seasonally weaker cash flow period. On a year-to-date basis, cash flow from operating activities was $438.1 million, and free cash flow was $252.7 million. Total debt at the end of the third quarter was $3,972.3 million, with financial net debt totaling $3,712.1 million, resulting in a financial leverage ratio of 3.4x.

Summarized from source with an LLMView Source

Key figures

-20.1%1Y
10.9%3Y
-11.7%5Y

Performance

32.6%1Y
42.6%3Y
62.6%5Y

Volatility

Market cap

8036 M

Market cap (USD)

Daily traded volume (Shares)

854,707

Daily traded volume (Shares)

1 day high/low

9.445 / 9.195

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Amgen Inc
Amgen Inc Amgen Inc Valor: 907582
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.04%USD 332.92
Intuitive Surgical Inc
Intuitive Surgical Inc Intuitive Surgical Inc Valor: 1631646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.25%USD 482.09
Kenvue Inc
Kenvue Inc Kenvue Inc Valor: 124280948
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.86%USD 23.19
Cardinal Health Inc
Cardinal Health Inc Cardinal Health Inc Valor: 196652
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%USD 111.41
SOLVENTUM CORP
SOLVENTUM CORP SOLVENTUM CORP Valor: 133635906
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.28%USD 72.13
WELL Health Technologies Corp
WELL Health Technologies Corp WELL Health Technologies Corp Valor: 42769021
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.68%CAD 4.35
Perrigo Company PLC
Perrigo Company PLC Perrigo Company PLC Valor: 22008864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%USD 28.16
TAL Education Group
TAL Education Group TAL Education Group Valor: 11869921
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.31%USD 7.56
Envista Holdings Corporation
Envista Holdings Corporation Envista Holdings Corporation Valor: 49153522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.95%USD 19.18
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 163523
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.06%USD 78.58